INNOVATIVE METHODOLOGY FOR PHARMACEUTICAL EXPENDITURE FORECAST

被引：1

作者：

Remuzat, C. ^{[1
]}

Toumi, M. ^{[2
]}

Cetinsoy, L. ^{[1
]}

Vataire, A. L. ^{[1
]}

Aballea, S. ^{[1
]}

机构：

[1] Creat Ceut France, Paris, France

[2] Univ Lyon 1, F-69365 Lyon, France

来源：

VALUE IN HEALTH | 2013年 / 16卷 / 03期

关键词：

D O I：

10.1016/j.jval.2013.03.1309

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A256 / A256

页数：1

共 50 条

[1] EU PHARMACEUTICAL EXPENDITURE FORECAST
Remuzat, C.
Toumi, M.
Vataire, A. L.
Cetinsoy, L.
VALUE IN HEALTH, 2013, 16 (03) : A254 - A255
[2] Equity of access to innovative drugs and sustainability of pharmaceutical expenditure
Eandi, Mario
FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2010, 11 (02) : 53 - 54
[3] PHARMACEUTICAL EXPENDITURE FORECAST MODEL TO SUPPORT HEALTH POLICY DECISION MAKING
Remuzat, C.
Toumi, M.
Vataire, A. L.
Cetinsoy, L.
Aballea, S.
VALUE IN HEALTH, 2013, 16 (03) : A255 - A255
[4] Pharmaceutical expenditure in Sweden
Henriksson, F
Hjortsberg, C
Rehnberg, C
HEALTH POLICY, 1999, 47 (02) : 125 - 144
[5] RESEARCH EXPENDITURE IN PHARMACEUTICAL INDUSTRY
不详
NATURE, 1964, 202 (492) : 140 - &
[6] Pharmaceutical expenditure - a burning issue
Groendal, Gerdur
Bjoernsson, Einar S.
LAEKNABLADID, 2013, 99 (05): : 233 - 233
[7] THE SUSTAINABILITY OF IRISH PHARMACEUTICAL EXPENDITURE
Walshe, V
Kenneally, M.
VALUE IN HEALTH, 2013, 16 (07) : A469 - A469
[8] The Forecast Pro methodology
Goodrich, RL
INTERNATIONAL JOURNAL OF FORECASTING, 2000, 16 (04) : 533 - 535
[9] PHARMACEUTICAL EXPENDITURE, TOTAL HEALTH-CARE EXPENDITURE AND GDP
Clemente, Jesus
Marcuello, Carmen
Montanes, Antonio
HEALTH ECONOMICS, 2008, 17 (10) : 1187 - 1206
[10] Understanding the components of pharmaceutical expenditure-overview of pharmaceutical policies influencing expenditure across European countries
Vogler, Sabine
Zimmermann, Nina
Habl, Claudia
GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2013, 2 (04): : 178 - 187

← 1 2 3 4 5 →